- About Pancreatic Cancer
- Get Support
Caregivers
- Get Involved
- Events
- More
2023-10-07
2024-02-15
2024-02-28
250
NCT06208436
Tianjin Medical University Cancer Institute and Hospital
Tianjin Medical University Cancer Institute and Hospital
OBSERVATIONAL
The Survival Outcome of Adjuvant Chemotherapy for Stage I Pancreatic Cancer
This study aimed to evaluate the impact of adjuvant chemotherapy on survival in patients with Stage I pancreatic cancer stratified by pathologic risk factors.
N/A
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
| Study Registration Dates | Results Reporting Dates | Study Record Updates |
|---|---|---|
2023-12-25 | N/A | 2024-01-06 |
2024-01-06 | N/A | 2024-01-17 |
2024-01-17 | N/A | 2024-01 |
This section provides details of the study plan, including how the study is designed and what the study is measuring.
Primary Purpose:
N/A
Allocation:
N/A
Interventional Model:
N/A
Masking:
N/A
Arms and Interventions
| Participant Group/Arm | Intervention/Treatment |
|---|---|
| : TMUCIH-PDAC Between 2010 and 2021, the data of patients who underwent surgical resection and were pathologically diagnosed as PDAC from Tianjin Medical University Cancer Institute and Hospital (TMUCIH) were collected retrospectively. | OTHER: Adjuvant chemotherapy
|
| Primary Outcome Measures | Measure Description | Time Frame |
|---|---|---|
| Recurrence-free survival | The period between surgical resection to the date of recurrence. | January 2010 to February 2023 |
| Secondary Outcome Measures | Measure Description | Time Frame |
|---|---|---|
| Overall survival | The period between surgical resection to the date of death. | January 2010 to February 2023 |
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.
Ages Eligible for Study:
ALL
Sexes Eligible for Study:
18 Years
Accepts Healthy Volunteers:
This is where you will find people and organizations involved with this study.
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
No publications available
